PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23300844-5	2012	Low-dose 5-aza induces a p53 transcriptional signature distinct from that induced with cisplatin in NT2/D1 cells and also uniquely downregulates genes associated with pluripotency including NANOG, SOX2, GDF3 and Myc target genes.	Azacitidine	9-14	Nanog homeobox	Homo sapiens	190-195	
23298400-9	2013	Nanog-positive iHAMs treated with 5-aza expressed Nkx2.5, GATA-4, human atrial natriuretic peptide (hANP), cardiac troponin T (cTnT), myocin light chain (Mlc)-2a, Mlc-2v, beta-myosin heavy chain (beta-MHC), hyperpolarization-activated cyclic nucleotide gated channels (HCN)-4, and inwardly rectifying potassium channels (Kir)-2.1.	Azacitidine	34-39	Nanog homeobox	Homo sapiens	0-5	
21194951-5	2011	Nanog also enhances reprogramming in cooperation with kinase inhibition or 5-aza-cytidine, a small molecule inhibitor of DNA methylation.	Azacitidine	75-89	Nanog homeobox	Homo sapiens	0-5	
15351705-5	2004	Moreover, 5-AzaC increased the expressions of ES specific markers, SSEA-1, and alkaline phosphatase activity as well as ES specific genes, Oct4, Nanog, and Sox2.	Azacitidine	10-16	Nanog homeobox	Homo sapiens	145-150	
31863652-8	2020	Epigenetic modification of the ADSCs by 5"-Aza and VPA significantly upregulated the expression of OCT4A, SOX2, NANOG, Brachyury/T and GATA4 but downregulated GSC and NES mRNAs.	Azacitidine	40-46	Nanog homeobox	Homo sapiens	112-117